ArticleJournal of translational medicine2020

Phase I and registry study of autologous bone marrow concentrate evaluated in PDE5 inhibitor refractory erectile dysfunction.

Mark Bieri et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.